What is the global market size of Pharmaceutical Analytical Testing Outsourcing Market?

Global Pharmaceutical Analytical Testing Outsourcing Market size was valued at USD 7.30 billion in 2021 and is poised to grow from USD 7.91 billion in 2022 to USD 15.09 billion by 2030, at a CAGR of 8.4% during the forecast period (2023-2030).

What is the key driver of Global Pharmaceutical Analytical Testing Outsourcing Market?

One driver propelling the growth of the global pharmaceutical analytical testing outsourcing market is the increasing demand for outsourcing services by pharmaceutical companies. Outsourcing analytical testing services allows pharmaceutical companies to focus on their core competencies, such as drug discovery and development, while leveraging the expertise and specialized infrastructure of contract research organizations (CROs). This enables them to streamline operations, reduce costs, and accelerate time-to-market for new drugs. For example, a pharmaceutical company may outsource analytical testing for quality control purposes, ensuring that its products meet regulatory standards and are safe for consumption.

What is the key market trend for Global Pharmaceutical Analytical Testing Outsourcing Market?

Increasing Adoption of Advanced Analytical Techniques: One emerging trend in the pharmaceutical analytical testing outsourcing market is the increasing adoption of advanced analytical techniques. With the development of innovative drug therapies and personalized medicine, there is a growing demand for specialized analytical testing services such as genomics, proteomics, metabolomics, and bioanalytical testing. Outsourcing partners with expertise in these advanced techniques can offer pharmaceutical companies access to cutting-edge technologies and analytical expertise, enabling them to leverage the full potential of their drug candidates.

Which region accounted for the largest share in Global Pharmaceutical Analytical Testing Outsourcing Market?

In the global pharmaceutical analytical testing outsourcing market, one of the dominating regions in North America. North America holds a significant share of the market due to several key factors. Firstly, the region is home to a large number of pharmaceutical companies, including both established players and emerging biotechnology firms. These companies require extensive analytical testing services to ensure the safety, quality, and efficacy of their products. The presence of a robust pharmaceutical industry and a strong focus on regulatory compliance in North America drives the demand for analytical testing outsourcing services. Secondly, North America boasts advanced healthcare infrastructure and a well-established regulatory framework. The stringent regulations set by the U.S. Food and Drug Administration (FDA) and other regulatory authorities necessitate comprehensive analytical testing to comply with regulatory guidelines. Pharmaceutical companies in the region rely on outsourcing partners with expertise in analytical testing to meet regulatory requirements and accelerate the drug development and approval process.

Pharmaceutical Analytical Testing Outsourcing Market Size, Share, Growth Analysis, By Services (Bioanalytical Testing, Method Development & Validation), By End Use (Pharmaceutical Companies, Biopharmaceutical Companies), By Region - Industry Forecast 2025-2032

Q: Who are the key vendors in the Global Pharmaceutical Analytical Testing Outsourcing Market?

The Global Pharmaceutical Analytical Testing Outsourcing Market is characterized by intense competition among key players operating in the industry. The market analysis reveals the presence of several prominent companies striving to enhance their market share and provide comprehensive analytical testing services to pharmaceutical companies. Some of the major players in the pharmaceutical analytical testing outsourcing market have established their strong presence in the market by offering a wide range of analytical testing services, including raw material testing, method development and validation, stability testing, and microbiological testing. They leverage their state-of-the-art laboratories, advanced technologies, and expertise in regulatory compliance to deliver accurate and reliable testing results. These key players also emphasize strategic partnerships, collaborations, and acquisitions to expand their service offerings, global reach, and customer base. Moreover, with the increasing complexities in drug development, quality control, and regulatory requirements, these companies invest heavily in research and development to stay at the forefront of analytical testing capabilities. 'Eurofins Scientific SE (Luxembourg)', 'Laboratory Corporation of America Holdings (US)', 'Charles River Laboratories International, Inc. (US)', 'WuXi AppTec (China)', 'SGS SA (Switzerland)', 'PPD, Inc. (US)', 'Intertek Group plc (UK)', 'Almac Group (UK)', 'Pace Analytical Services, LLC (US)', 'Source BioScience plc (UK)', 'Syneos Health (US)', 'BioReliance Corporation (US)', 'LGC Limited (UK)', 'Pharmaceutical Product Development, LLC (US)', 'Toxikon Corporation (US)', 'Avista Pharma Solutions (US)', 'Cambridgeshire Quality Services Ltd (UK)', 'Harlan Laboratories Ltd (UK)', 'Accutest Laboratories (US)', 'Neopharm Labs Inc. (Canada)'.

Report ID: SQMIG35C2024 | Region: Global | Published Date: October, 2024
Pages: 219 | Tables: 97 | Figures: 76

Pharmaceutical Analytical Testing Outsourcing Market News

In October 2024, Eurofins Scientific expanded its capabilities by acquiring a leading provider of clinical trial testing services, enhancing its service offering for pharmaceutical companies. This acquisition is expected to enhance Eurofins’ capabilities in the global outsourcing pharmaceutical analytical testing services market availed by drug makers for better regulatory compliance and product safety evaluation activities carried out in the course of drug development.
In September 2024, Labcorp Drug Development launched a new suite of bioanalytical testing services focused on biologics and gene therapies. This development improves the company’s ability to offer high-precision analytical testing for complex biologic drugs, addressing the growing demand for biologic development and accelerating time-to-market for pharmaceutical companies.
In August 2024, Charles River Laboratories opened a state-of-the-art facility in Singapore, aimed at enhancing its bioanalytical testing capabilities for clients in the Asia-Pacific region. The upgraded center prioritizes enhancing the drug development process via more sophisticated testing services, upholding global standards, and assisting in the overseas growth of the organization.

Pharmaceutical Analytical Testing Outsourcing Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Pharmaceutical Analytical Testing Outsourcing Market size was valued at USD 7.62 billion in 2022 and is poised to grow from USD 8.32 billion in 2023 to USD 15.89 billion by 2031, growing at a CAGR of 8.42% during the forecast period (2024-2031).

The global pharmaceutical analytical testing outsourcing industry has a competitive environment that consists of both well-known international corporations and some emerging niche players. Eurofins Scientific, Labcorp Drug Development, Charles River Laboratories and WuXi AppTec are among the companies that provide an array of testing services together with regulatory compliance and the latest technologies. These players endeavor to strengthen their service portfolios and increase their footprint globally in response to the rise in demand for efficient analytical testing services in the pharmaceutical vertical. 'Eurofins Scientific SE ', 'Laboratory Corporation of America Holdings ', 'Charles River Laboratories International, Inc. ', 'WuXi AppTec ', 'SGS SA ', 'PPD, Inc. ', 'Intertek Group plc ', 'Almac Group ', 'Pace Analytical Services, LLC ', 'Source BioScience plc ', 'Syneos Health ', 'BioReliance Corporation ', 'LGC Limited ', 'Pharmaceutical Product Development, LLC ', 'Toxikon Corporation ', 'Avista Pharma Solutions ', 'Harlan Laboratories Ltd ', 'Accutest Laboratories ', 'Neopharm Labs Inc. '

With the global regulatory demands becoming more and more serious, ensuring compliance with drug safety and effectiveness becomes important for pharmaceutical manufacturers. The increasing demand for outsourced analytical testing services is primarily driven by the need among firms to obtain specialized skills, minimize the chances of failing to adhere to regulatory requirements, and ensure the quality of the firm's products.

Rising Demand for Biologic Drug Testing: The increasing focus on biologics and biosimilars is driving demand for specialized pharmaceutical analytical testing outsourcing services. Outsourcing bioanalytical tests is a great benefit for the pharmaceutical companies, as it allows them to take advantage of modern technologies as well as skills, in the development of the biologics, which in turn, safeguards the quality and regulatory requirements of the best complicated drugs.

Europe dominates the global pharmaceutical analytical testing outsourcing market due to its strong regulatory frameworks, well-established pharmaceutical industry, and extensive infrastructure for drug development and testing. The region has mastered the presence of many pharmaceutical companies and research institutions, which have built a high level of innovation. Ethospa's regional market is further enhanced by Europe's high standards of drug safety and efficacy and the growing appetite for top quality testing services. In addition, lower cost of service delivery through outsourcing, sophisticated bioanalytical methods as well as the concentration of clinical trials in the region make Europe to command the market thus making it the major player in the global pharmaceutical analytical testing outsourcing market.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Pharmaceutical Analytical Testing Outsourcing Market Size, Share, Growth Analysis, By Services (Bioanalytical Testing, Method Development & Validation), By End Use (Pharmaceutical Companies, Biopharmaceutical Companies), By Region - Industry Forecast 2025-2032

Pharmaceutical Analytical Testing Outsourcing Market News

Pharmaceutical Analytical Testing Outsourcing Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Pharmaceutical Analytical Testing Outsourcing Market?

Who are the key vendors in the Pharmaceutical Analytical Testing Outsourcing Market?

What is the key driver of Pharmaceutical Analytical Testing Outsourcing Market?

What is the key market trend for Pharmaceutical Analytical Testing Outsourcing Market?

Which region accounted for the largest share in Pharmaceutical Analytical Testing Outsourcing Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300